|
Bionano Genomics Inc (NASDAQ: BNGO) |
|
Bionano Genomics Inc
BNGO's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Bionano Genomics Inc 's sales fell
by -29.89 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 1110
Laboratory Analytical Instruments industry recorded
growth of revenues by 1.41 %
Bionano Genomics Inc net loss increased from $-39 millions, to $-44 millions in III. Quarter 2024,
• More on BNGO's Growth
|
|
Bionano Genomics Inc realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 0.99 in trailing twelve-month period. Laboratory Analytical Instruments industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
10.56 |
PE TTM
|
|
Company's Price to Sales ratio is at 0.33.
Laboratory Analytical Instruments industry's Price to Sales ratio is at 5.75.
• More on BNGO's Valuation
|
|
|
|
|
Bionano Genomics Inc realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 0.99 in trailing twelve-month period. Laboratory Analytical Instruments industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
10.56 |
PE TTM
|
|
Company's Price to Sales ratio is at 0.33.
Laboratory Analytical Instruments industry's Price to Sales ratio is at 5.75.
Bionano Genomics Inc Price to Book Ratio is at 0.21 lower than Industry Avg. of 307.11. and higher than S&P 500 Avg. of 0.01
• More on BNGO's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com